Inventor · disambiguated record
Meera Ramanujam
Also filed as: RAMANUJAM Meera
1 granted patent·9 pending applications·0 citations·filing 2016–2024
14Inventor score
Top patents by PatentIndex Score
10 records- 0169US2024392019A1Anti-il-36r antibodies for the treatment of neutrophilic dermatosesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0265US2023265203A1Use of anti-cd40 antibodies for treatment of lupus nephritisBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0364US12098207B2Anti-IL-36R antibodies for the treatment of pyoderma gangrenosumBOEHRINGER INGELHEIM INT·Filed 2021·Granted Sep 24, 2024·0 cites·8 claims
- 0464US2024317875A1Use of anti-cd40 antibodies for treatment of inflammatory conditionsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0563US2024175034A1Fn3 domain-sirna conjugates and uses thereofAro Biotherapeutics Company·Filed 2023·Application pending·0 cites
- 0654US2023049147A1Anti-il-36r antibodies for the treatment of a fibrotic conditionBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0752US2022089759A1Use of anti-cd40 antibodies for treatment of inflammatory conditionsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0849US2022010022A1Anti-il-36r antibodies for the treatment of atopic dermatitisBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0947US2019177420A1Use of anti-cd40 antibodies for treatment of lupus nephritisBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1041US2017058038A1Use of anti-cd40 antibodies for treatment of lupus nephritisBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →